viernes, 18 de marzo de 2022

COVID-19: WHO updates living drugs guidance: molnupiravir, casirivimab-imdevimab restrictions underscored

COVID-19: WHO updates living drugs guidance: molnupiravir, casirivimab-imdevimab restrictions underscored

No hay comentarios:

Publicar un comentario